Lexaria Bioscience -CW25LEXXWPreferred / convertible
13F holders, Q4 2025 (December 31)3holders −1
1new positions
2sold out
$0.00avg. 13F price*
At the end of Q4 2025, 3 institutions reported holding Lexaria Bioscience -CW25 (LEXXW) in their 13F filings, down 1 from Q3 2025. 1 opened new positions and 2 sold out. The largest holders were Two Sigma Securities, LLC ($96), Clear Street Group Inc. ($1) and HRT Financial LP ($0).
- Company
- Lexaria Bioscience -CW25
- CUSIP
- 52886N117
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $96 |
| Exits | 2 | $3K |
All 13F filers, Q3 2025 → Q4 2025: 117,196 shares bought and 43,675 shares sold, net +73,521 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Two Sigma Securities, LLC | — | New | 22,919 | $96 |
| Clear Street Group Inc. | — | Add +100.0% | 200 | $1 |
| HRT Financial LP | — | Add +832.4% | 105,491 | $0 |
"% of holder's portfolio" is LEXXW's weight in each manager's 13F, not the share of Lexaria Bioscience -CW25 the manager owns.